The manufacturer of aripiprazole (Abilify and others), which is now off patent, has released a similar drug called brexpiprazole (Rexulti), which the FDA has approved to treat schizophrenia and as an adjunct to antidepressants for major depressive disorder (MDD).
Several recent reviews question the evidence for the efficacy of medical marijuana and caution about its potential long-term side effects.
Vitamin D Deficiency Associated with Increased Cognitive Decline in Older Adults; High-Glycemic Diets Associated with Increased Risk of Depression in Postmenopausal Women
Nitrous Oxide for Depression?
A pilot study of nitrous oxide inhalation for patients with treatment-resistant depression has yielded positive results.
Frequently Asked Questions
What should I do if I don't know my password?
You can go to the "Support" button and click on the "Forgot Password?" option. Your password will be emailed to you.
What is my username?
Your username is your full email address.
Does my username have to be an email address?
Yes. Our system sends monthly notices to your email address that is tied to the login function of the site.
If we have an institutional subscription, can we have multiple usernames?
No. You must have one main username/email address.
I am missing an issue. How can I get a replacement?
Simply click on the "Contact Us" link (under Support). Indicate the issue that you are missing and your current mailing address. We will verify our records and send a replacement. You may also call us at 800-700-9589 or 520-572-2039 (outside U.S.).
I need to renew my subscription. What is the easiest way to get this done?
Simply click on the "Subscribe" button and follow the prompts to subscribe via our secure online server or call us at 800-700-9589 or 520-572-2039 (outside U.S.) to subscribe by phone.
What credit cards do you accept?
We accept Visa and MasterCard.